PEGBIO CO-B (02565) has announced that on November 2, 2026 (after trading hours), the company entered into a placing agreement with a sole placing agent, under which the company has conditionally agreed to place a total of 26.813 million placing shares through the sole placing agent on a best-efforts basis at a price of HK$2.985 per placing share to not fewer than six placees. These placing shares will be issued by the company under a general mandate in accordance with the terms and conditions set out in the placing agreement.
As of the date of this announcement, the company has 391 million issued shares, including 386 million H shares and 5.0891 million unlisted shares. Assuming there is no change in the company's issued share capital from the date of this announcement to the completion date, the total of 26.813 million placing shares represents: (i) approximately 6.95% of the issued H shares and approximately 6.86% of the total issued shares as of the date of this announcement; and (ii) approximately 6.50% of the H shares and approximately 6.42% of the total shares as enlarged by the allotment and issue of the placing shares.
The placing price is HK$2.985 per placing share, representing a discount of 19.00% to the closing price of HK$3.685 per H share as reported on the Stock Exchange on November 2, 2026 (Hong Kong time), the date of the placing agreement. Assuming all placing shares are fully placed, the estimated gross proceeds and net proceeds from the placing, after deducting relevant costs and expenses to be borne by the company, will be approximately HK$80.04 million and approximately HK$77.16 million, respectively.
Comments